Nonalcoholic Fatty Liver Disease Increases Risk for Gastroesophageal Reflux Symptoms
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Nonalcoholic fatty liver disease (NAFLD) is now recognized as a leading cause of liver dysfunction. Gastroesophageal reflux disease (GERD) is a common disorder causing symptoms that often impair patients’ quality of life. In recent years, the prevalence of both these diseases has increased, partially overlapping the rise of metabolic disorders.
Cross-sectional study among 206 outpatients diagnosed with NAFLD and 183 controls. We collected clinical and laboratory data, assessed severity and frequency of GERD symptoms and the esophageal endoscopic pattern.
The prevalence of GERD symptoms was higher in NAFLD patients than controls (61.2 vs. 27.9 %, p < 0.001). We found a positive association between NAFLD and the experiencing of heartburn, regurgitation and belching. GERD symptoms were related to body mass index (BMI) and metabolic syndrome (MetS); a strong association persisted after adjustment for all the covariates (adjusted OR 3.49, 95 CI % 2.24–5.44, p < 0.001).
Our data show that the prevalence of GERD typical symptoms is higher in patients with NAFLD. GERD was associated with higher BMI and MetS, but not with age and diabetes type 2. NAFLD remained strongly associated with GERD, independently of a coexisting MetS status. Consistent with these findings, MetS can be considered a shared background, but cannot completely explain this correlation. We suggest NAFLD as an independent risk factor for GERD symptoms.
- Blachier, M, Leleu, H, Peck-Radosavljevic, M, Valla, DC, Roudot-Thoraval, F (2013) The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol 58: pp. 593-608 CrossRef
- Tarantino, G, Saldalamacchia, G, Conca, P, Arena, A (2007) Non-alcoholic fatty liver disease: further expression of the metabolic syndrome. J Gastroenterol Hepatol 22: pp. 293-303 CrossRef
- Kopec, KL, Burns, D (2011) Nonalcoholic fatty liver disease: a review of the spectrum of disease, diagnosis, and therapy. Nutr Clin Pract 26: pp. 565-576 CrossRef
- Attar, BM, Thiel, DH (2013) Current concepts and management approaches in nonalcoholic fatty liver disease. Sci World J 2013: pp. 481893 CrossRef
- Obika, M, Noguchi, H (2012) Diagnosis and evaluation of nonalcoholic fatty liver disease. Exp Diabetes Res 2012: pp. 145754 CrossRef
- Lipan, MJ, Reidenberg, JS, Laitman, JT (2006) Anatomy of reflux: a growing health problem affecting structures of the head and neck. Anat Rec B New Anat 289: pp. 261-270 CrossRef
- Wu, P, Zhao, XH, Ai, ZS (2013) Dietary intake and risk for reflux esophagitis: a case-control study. Gastroenterol Res Pract 2013: pp. 691026
- Ronkainen, J, Agréus, L (2013) Epidemiology of reflux symptoms and GORD. Best Pract Res Clin Gastroenterol 27: pp. 325-337 CrossRef
- El-Serag, HB, Sweet, S, Winchester, CC, Dent, J (2013) Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut.
- Camilleri, M, Dubois, D, Coulie, B (2005) Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol 3: pp. 543-552 CrossRef
- Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106: pp. 3143-3421
- Standards of Practice Committee, Lichtenstein DR, Cash BD, et al. Role of endoscopy in the management of GERD. Gastrointest Endosc. 2007;66(2):219–24.
- Krishnan, B, Babu, S, Walker, J, Walker, AB, Pappachan, JM (2013) Gastrointestinal complications of diabetes mellitus. World J Diabetes 4: pp. 51-63 CrossRef
- Promberger, R, Lenglinger, J, Riedl, O (2013) Gastro-oesophageal reflux disease in type 2 diabetics: symptom load and pathophysiologic aspects—a retro-pro study. BMC Gastroenterol 13: pp. 132 CrossRef
- Ayazi, S, Hagen, JA, Chan, LS (2009) Obesity and gastroesophageal reflux: quantifying the association between body mass index, esophageal acid exposure, and lower esophageal sphincter status in a large series of patients with reflux symptoms. J Gastrointest Surg 13: pp. 1440-1447 CrossRef
- Hampel, H, Abraham, NS, El-Serag, HB (2005) Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 143: pp. 199-211 CrossRef
- El-Serag, HB, Graham, DY, Satia, JA, Rabeneck, L (2005) Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol 100: pp. 1243-1250 CrossRef
- Ierardi, E, Rosania, R, Zotti, M (2010) Metabolic syndrome and gastro-esophageal reflux: a link towards a growing interest in developed countries. World J Gastrointest Pathophysiol 1: pp. 91-96 CrossRef
- Lee, YC, Yen, AM, Tai, JJ (2009) The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux disease. Gut 58: pp. 174-181 CrossRef
- Festi, D, Scaioli, E, Baldi, F (2009) Body weight, lifestyle, dietary habits and gastroesophageal reflux disease. World J Gastroenterol 15: pp. 1690-1701 CrossRef
- Jung, HS, Choi, MG, Baeg, MK (2013) Obesity is associated with increasing esophageal acid exposure in Korean patients with gastroesophageal reflux disease symptoms. J Neurogastroenterol Motil 19: pp. 338-343 CrossRef
- Hajar, N, Castell, DO, Ghomrawi, H, Rackett, R, Hila, A (2012) Impedance pH confirms the relationship between GERD and BMI. Dig Dis Sci 57: pp. 1875-1879 CrossRef
- Fox, M, Barr, C, Nolan, S, Lomer, M, Anggiansah, A, Wong, T (2007) The effects of dietary fat and calorie density on esophageal acid exposure and reflux symptoms. Clin Gastroenterol Hepatol 5: pp. 439-444 CrossRef
- Wu, JC, Mui, LM, Cheung, CM, Chan, Y, Sung, JJ (2007) Obesity is associated with increased transient lower esophageal sphincter relaxation. Gastroenterology 132: pp. 883-889 CrossRef
- Shapiro, M, Green, C, Bautista, JM (2007) Assessment of dietary nutrients that influence perception of intra-oesophageal acid reflux events in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther 25: pp. 93-101 CrossRef
- Lacy BE, Carter J, Weiss JE, et al. The effects of intraduodenal nutrient infusion on serum CCK, LES pressure, and gastroesophageal reflux. Neurogastroenterol Motil. 2011;23(7):631–e256.
- Holloway, RH, Lyrenas, E, Ireland, A, Dent, J (1997) Effect of intraduodenal fat on lower oesophageal sphincter function and gastro-oesophageal reflux. Gut 40: pp. 449-453
- Altomare A, Ma J, Guarino MP, et al. Platelet-activating factor and distinct chemokines are elevated in mucosal biopsies of erosive compared with non-erosive reflux disease patients and controls. Neurogastroenterol Motil. 2012;24(10):943–e463.
- Souza, RF, Huo, X, Mittal, V (2009) Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology 137: pp. 1776-1784 CrossRef
- Mönkemüller, K, Wex, T, Kuester, D (2009) Interleukin-1beta and interleukin-8 expression correlate with the histomorphological changes in esophageal mucosa of patients with erosive and non-erosive reflux disease. Digestion 79: pp. 186-195 CrossRef
- Rieder, F, Cheng, L, Harnett, KM (2007) Gastroesophageal reflux disease-associated esophagitis induces endogenous cytokine production leading to motor abnormalities. Gastroenterology 132: pp. 154-165 CrossRef
- Yoshida, N, Uchiyama, K, Kuroda, M (2004) Interleukin-8 expression in the esophageal mucosa of patients with gastroesophageal reflux disease. Scand J Gastroenterol 39: pp. 816-822 CrossRef
- Isomoto, H, Saenko, VA, Kanazawa, Y (2004) Enhanced expression of interleukin-8 and activation of nuclear factor kappa-B in endoscopy-negative gastroesophageal reflux disease. Am J Gastroenterol 99: pp. 589-597 CrossRef
- Ma, J, Altomare, A, Monte, S (2010) HCl-induced inflammatory mediators in esophageal mucosa increase migration and production of H2O2 by peripheral blood leukocytes. Am J Physiol Gastrointest Liver Physiol 299: pp. G791-G798 CrossRef
- Tutuian, R, Castell, DO (2006) Review article: complete gastro-oesophageal reflux monitoring—combined pH and impedance. Aliment Pharmacol Ther 24: pp. 27-37 CrossRef
- McGown, C, Birerdinc, A, Younossi, ZM (2014) Adipose tissue as an endocrine organ. Clin Liver Dis 18: pp. 41-58 CrossRef
- Coelho, M, Oliveira, T, Fernandes, R (2013) Biochemistry of adipose tissue: an endocrine organ. Arch Med Sci 9: pp. 191-200 CrossRef
- Kwon, H, Pessin, JE (2013) Adipokines mediate inflammation and insulin resistance. Front Endocrinol 4: pp. 71 CrossRef
- Haase J, Weyer U, Immig K, et al. Local proliferation of macrophages in adipose tissue during obesity-induced inflammation. Diabetologia. 2013. doi:10.1007/s00125-013-3139-y.
- Blüher, M (2013) Adipose tissue dysfunction contributes to obesity related metabolic diseases. Best Pract Res Clin Endocrinol Metab 27: pp. 163-177 CrossRef
- Harwood, HJ (2012) The adipocyte as an endocrine organ in the regulation of metabolic homeostasis. Neuropharmacology 63: pp. 57-75 CrossRef
- Braunersreuther, V, Viviani, GL, Mach, F, Montecucco, F (2012) Role of cytokines and chemokines in non-alcoholic fatty liver disease. World J Gastroenterol 18: pp. 727-735 CrossRef
- Jarrar, MH, Baranova, A, Collantes, R (2008) Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment Pharmacol Ther 27: pp. 412-421 CrossRef
- García-Galiano, D, Sánchez-Garrido, MA, Espejo, I (2007) IL-6 and IGF-1 are independent prognostic factors of liver steatosis and non-alcoholic steatohepatitis in morbidly obese patients. Obes Surg 17: pp. 493-503 CrossRef
- Karbownik-Lewinska, M, Szosland, J (2012) Direct contribution of obesity to oxidative damage to macromolecules. Neuro Endocrinol Lett 33: pp. 453-461
- Palmieri, VO, Grattagliano, I, Portincasa, P, Palasciano, G (2006) Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome. J Nutr 136: pp. 3022-3026
- Furukawa, S, Fujita, T, Shimabukuro, M (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114: pp. 1752-1761 CrossRef
- Kim, YJ, Kim, EH, Hahm, KB (2012) Oxidative stress in inflammation-based gastrointestinal tract diseases: challenges and opportunities. J Gastroenterol Hepatol 27: pp. 1004-1010 CrossRef
- Erbil, Y, Türkoglu, U, Barbaros, U (2005) Oxidative damage in an experimentally induced gastric and gastroduodenal reflux model. Surg Innov 12: pp. 219-225 CrossRef
- Wetscher GJ, Hinder RA, Bagchi D, et al. Reflux esophagitis in humans is mediated by oxygen-derived free radicals. Am J Surg. 1995;170(6):552–556; discussion 556–557.
- Farhadi, A, Fields, J, Banan, A, Keshavarzian, A (2002) Reactive oxygen species: are they involved in the pathogenesis of GERD, Barrett’s esophagus, and the latter’s progression toward esophageal cancer?. Am J Gastroenterol 97: pp. 22-26 CrossRef
- Oh, TY, Lee, JS, Ahn, BO (2001) Oxidative damages are critical in pathogenesis of reflux esophagitis: implication of antioxidants in its treatment. Free Radic Biol Med 30: pp. 905-915 CrossRef
- Basaranoglu, M, Basaranoglu, G, Sentürk, H (2013) From fatty liver to fibrosis: a tale of “second hit”. World J Gastroenterol 19: pp. 1158-1165 CrossRef
- Jaeschke, H (2011) Reactive oxygen and mechanisms of inflammatory liver injury: present concepts. J Gastroenterol Hepatol 26: pp. 173-179 CrossRef
- Seki, S, Kitada, T, Sakaguchi, H (2005) Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases. Hepatol Res 33: pp. 132-134 CrossRef
- Chalasani, N, Deeg, MA, Crabb, DW (2004) Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 99: pp. 1497-1502 CrossRef
- Wier, B, Balk, JM, Haenen, GR (2013) Elevated citrate levels in non-alcoholic fatty liver disease: the potential of citrate to promote radical production. FEBS Lett 587: pp. 2461-2466 CrossRef
- Duseja, A, Chawla, YK (2014) Obesity and NAFLD: the role of bacteria and microbiota. Clin Liver Dis 18: pp. 59-71 CrossRef
- Miele, L, Cammarota, G, Vero, V (2012) Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms. Dig Liver Dis 44: pp. 1032-1036 CrossRef
- Fujikawa, Y, Tominaga, K, Fujii, H (2012) High prevalence of gastroesophageal reflux symptoms in Patients with non-alcoholic fatty liver disease associated with serum levels of triglyceride and cholesterol but not simple visceral obesity. Digestion 86: pp. 228-237 CrossRef
- Nonalcoholic Fatty Liver Disease Increases Risk for Gastroesophageal Reflux Symptoms
Digestive Diseases and Sciences
Volume 59, Issue 8 , pp 1939-1945
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Nonalcoholic fatty liver
- Gastroesophageal reflux disease
- Metabolic syndrome
- Industry Sectors
- Author Affiliations
- 1. Section of Gastroenterology, Department of Medical and Pediatric Sciences, Institute of Internal Medicine “A. Francaviglia”, University of Catania, “G. Rodolico” Hospital, Bldg. 4 - I Floor, Room 17, Via S. Sofia, 78, 95123, Catania, Italy
- 2. ReGenera Research Group for Aging Intervention, Piazza Firenze, 12, 20154, Milan, Italy